北里
TSE Prime ・ Ticker 368A ・ Listed
Updated
Offer price
1,340 yen
First traded price
2,001 yen
Selling 100 shares at the first traded price would have produced a gain of 66,100 yen, before fees and tax. 100 shares is the minimum trading unit in Japan.
Compared with the first traded price of 2,001 yen.
You can only enter this lottery through a broker underwriting it. The joint lead underwriters are Nomura Securities, SMBC Nikko Securities, which receive the largest allocations.
Broker pages are in Japanese. A comparison in English is on the brokers page.
A medical device maker that supplies the culture media, freezing devices and fine instruments used in fertility clinics for IVF.
It develops, manufactures and sells products for clinics that carry out assisted reproduction - culture media for growing embryos, devices for freezing and storing eggs and embryos, and instruments such as egg-collection needles and pipettes for micro-insemination. Most are consumables used up in each treatment cycle, so sales repeat for as long as treatments continue. In the year to March 2025, sales by category were 3.61 billion yen for culture media (Media), 3.17 billion yen for freezing devices (Cryodevice), 2.32 billion yen for medical devices and 1.01 billion yen for micro tools.
Consolidated revenue rose to 10.95 billion yen in the year to March 2026, with operating profit of 5.86 billion yen, so more than half of revenue still comes through as operating profit. The company has published a three-year management plan covering the years to March 2027 through March 2029.
Read about this company in Japanese →Figures are taken from the offering documents and public sources, and are checked against two independent sources before publication. Nothing here is investment advice. Shares can and do open below their offer price.
